| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALUMIS INC. | Chief Medical Officer | Common Stock | 28,450 | $126,887 | $4.46 | 29 Jul 2025 | Direct |
| Ventyx Biosciences, Inc. | Chief Medical Officer | Stock Option (right to buy) | 145,000 | 04 Feb 2022 | Direct | ||
| ALUMIS INC. | Chief Medical Officer | Stock Option (Right to Buy) | 101,850 | 29 Jul 2025 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director | Stock Option (Right to buy) | 0 | 20 May 2024 | Direct |